In order to effectively do a good job in COVID-19 virus detection and epidemic prevention and control, and reduce the cost of large-scale nucleic acid detection and screening and high-frequency detection, Suzhou immediately implemented the spirit of the Notice of Anhui Medical and Social Security Bureau on Adjusting the Price of Nucleic Acid Testing Projects in novel coronavirus, and adjusted the price of nucleic acid testing in novel coronavirus, with effect from April 3, 222.
It is clear that the price of single sample testing for Covid-19 nucleic acid testing project in public medical institutions will be adjusted from 4 yuan to 28 yuan; The mixed detection of Covid-19 nucleic acids in accordance with relevant technical specifications does not distinguish the number of samples, and the price does not exceed 6 yuan/person. Non-public medical institutions and third-party testing institutions to provide Covid-19 nucleic acid testing services, pricing should follow the principle of "fairness, legality, honesty and credit", reflecting the low profit of capital preservation.
At the same time, public medical institutions are required to carry out novel coronavirus's nucleic acid testing service, and two service options, namely "single-person single-test" and "multi-person mixed-test", should be provided for the masses to choose voluntarily. Special windows should be set up, independent areas should be opened up, internal management processes should be optimized, and nucleic acid testing results should be pushed for the masses in an electronic and information-based way. Simply conducting nucleic acid testing does not require registration, and public medical institutions may not charge outpatient consultation fees or general consultation fees.
Recently, according to the spirit of the sixth notice of the Provincial Medical Insurance Bureau to adjust the price of nucleic acid testing, Suzhou Medical Insurance Bureau, together with the Municipal Health and Health Commission, issued the Notice on Adjusting the price of nucleic acid testing items in novel coronavirus, Suzhou, to adjust the price of nucleic acid testing in Covid-19 in time, so as to help the city's epidemic prevention and control and economic and social development.
since December 1st, 221, the highest price limit for single sample testing in Covid-19, a public medical institution in the city, has been reduced from 6 yuan/person-time to no more than 4 yuan/person-time, and the highest price limit for 5:1 mixed sample testing and 1:1 mixed sample testing has been uniformly adjusted to no more than 1 yuan/person-time.
The public medical institutions in the city should set up special windows, open up independent areas, optimize internal management processes, and provide the masses with the service of pushing nucleic acid test results in an electronic and information-based way; Simply conducting nucleic acid testing does not require registration, and public medical institutions may not charge outpatient consultation fees and general consultation fees.